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Abstract
Computational analysis of high-throughput omics data, such as gene expressions, 
copy number alterations and DNA methylation (DNAm), has become popular in 
disease studies in recent decades because such analyses can be very helpful to pre-
dict whether a patient has certain disease or its subtypes. However, due to the high-
dimensional nature of the data sets with hundreds of thousands of variables and very 
small number of samples, traditional machine learning approaches, such as support 
vector machines (SVMs) and random forests, have limitations to analyze these data 
efficiently. In this chapter, we reviewed the progress in applying deep learning algo-
rithms to solve some biological questions. The focus is on potential software tools and 
public data sources for the tasks. Particularly, we show some case studies using deep 
neural network (DNN) models for classifying molecular subtypes of breast cancer and 
DNN-based regression models to account for interindividual variation in triglyceride 
concentrations measured at different visits of peripheral blood samples using DNAm 
profiles. We show that integration of multi-omics profiles into DNN-based learning 
methods could improve the prediction of the molecular subtypes of breast cancer. We 
also demonstrate the superiority of our proposed DNN models over the SVM model 
for predicting triglyceride concentrations.
Keywords: deep learning, omics data, phenotypic traits, data integration, support 
vector machine, random forest
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1. Introduction
1.1. Omics data
Omics refers to use high-throughput experimental technologies to examine genomics, tran-
scriptomics, metabolomics and proteomics for understanding biological and disease mecha-
nisms. The omics data generated from these technologies are high-dimensional and correlated. 
Different computational and statistical analyses of these data can be used to identify risk fac-
tors for different diseases or to build autonomous disease prediction models. The technologi-
cal development allows researchers to have a huge amount of high-dimensional biological 
data. The omics technologies generate such high-throughput data by detecting numerous 
alterations in molecular components [1]. These technologies also generate additional biologi-
cal data to comprehend different types of correlations and dependencies among the molecular 
components. Bioinformatics is a discipline which emerges to perform computational analy-
sis with the high-throughput biological data. Bioinformatics offers tools and methodologies 
for analyzing different omics data to understand the underlying information about different 
diseases. Such analyses will help physicians to provide early and patient-specific treatment. 
Schneider and Orchard [2] listed the state-of-the-art available technologies to generate omics 
data. They also provided the list of different available bioinformatics resources to analyze 
omics data and discussed the bioinformatics challenges to handle the high-throughput data.
For example, one of the key questions in medical science is to identify the specific mutations 
for a particular disease in individual patients. To do this, we need to first collect blood sam-
ples from the patients with the disease and healthy individuals without diseases. DNA will 
be then extracted from these blood samples. DNA microarray (also named as DNA chip) or 
DNA sequencing technologies will be then used to generate genome-wide genomic data for 
identifying mutated genes for the disease [2]. Similar technologies and procedures can also 
be used to generate other types of omics data such as RNA gene expression data and DNA 
methylation (DNAm) data.
1.2. Phenotypic traits prediction
A living biological organism can show a number of observable characteristics such as morphol-
ogy, growth and behavior of the organism. Phenotypes are the product of different genetic 
expressions of an organism. These expressions are known as the genotype of that organism. 
However, phenotypic traits are the alternatives of a phenotype of a particular organism. For 
example, hair is a phenotype but different hair colors are the phenotypic traits. Study of the 
phenotypic traits prediction is very important as it gives us the knowledge about how geno-
type impacts upon an individual’s diseases or traits. Lippert et al. [3] used the whole-genome 
sequencing data to identify individuals by predicting their biometric traits. Genome sequenc-
ing data were also used by Chen et al. [4] to build a probabilistic Bayesian model to predict the 
dichotomous traits (e.g., glaucoma, Corn’s disease, prostate cancer). This model incorporates 
annotated information about different variant genotypes and genes, which are associated 
with diseases. There are other phenotypic trait prediction models such as eye color [5, 6], skin 
color [6] or facial structures [7].
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1.2.1. Breast cancer and its molecular subtypes
Cancer is a collection of diseases that are characterized by uncontrolled cell growth in organs, 
that is, the sites the cells originate from. For example, breast cancer begins in the breast tissue 
and may start in the duct or lobe of the breast. When the breast cells are not working properly, 
they divide continually and a tumor is formed. Breast cancer is a complex and heterogeneous 
disease with differing prognostic and clinical outcomes.
In clinical practice, estrogen-receptor expression can be used to classify breast cancer patients 
into estrogen-receptor positive (ER+) or negative (ER−). A patient is classified as ER+ if the stimu-
lation of growth of her cancer cells depends on the receptor for hormone estrogen. Stratification 
of breast cancer patients into ER+ or ER− is very important as physicians will use the informa-
tion to determine whether the patients need chemotherapy or hormonal treatments. Statistics 
show that approximately 67% of breast cancer tests are positive for hormone receptors [8].
Perou et al. discovered the intrinsic subtypes of breast cancer using gene expression profiles 
of frozen tissue samples through unsupervised analysis [9]. They classified breast cancers 
into five groups such as normal-like, luminal A and B (Lumb A and B), basal-like and Her2-
enriched (Her2). They established a polymerase chain reaction (PCR)-based test for 50 genes, 
and these genes are well-known as PAM50 signature. Gene expression levels of these 50 genes 
can be used to classify patients into one of these four subtypes: luminal A and B, basal-like 
and Her2-enriched. These subtypes are also known as PAM50 subtypes. This classification 
has been shown to be prognostically independent of clinicopathologic factors and can identify 
patients who are more likely to benefit from adjuvant chemotherapy [10]. It can also help iden-
tifying the fundamental differences among the PAM50 subtypes at the molecular level [11].
1.2.2. Prediction of triglyceride concentration in blood
Triglyceride is a type of fat in the human blood. Having a high concentration of triglycerides in 
human blood can increase our risk of heart diseases, stroke and other disorders. Many genetic 
loci have been identified by genome-wide association studies, but only a small proportion of 
interindividual variability of triglycerides has been explained by the genetic determinants. It 
is known that the level of triglycerides is heritable. Consequently, the development of new 
high-throughput genomic technologies makes it natural to extend these phenotypic predic-
tion models to complex traits such as triglyceride. Using DNAm profiles to predict disease 
phenotypic courses has not yet been explored in detail.
1.3. Machine learning for disease phenotype prediction
Artificial intelligence (AI) is an area of computer science which demonstrates its necessity in our 
everyday life by machine learning (ML) methods. ML methods can automate the data analysis and 
can find the hidden intrinsic patterns from big data, which is impossible for a human being. ML 
methods use these patterns to build predictive models without any explicit programming. These 
predictive ML models are improving our daily life in various ways such as recommendations of 
different products during online shopping based on our searches of products, stock price predic-
tion, classification of different objects from images, real-time language translation, and so on.
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Conventional ML methods, such as support vector machine (SVM), random forest (RF), 
Bayesian network (BN), and so on, are dependent on the well-defined, engineered and robust 
hand-tuned features (or feature vectors) as inputs from the raw input data to make reason-
able predictions. A domain human expertise is required to develop these engineered features. 
However, real-time biomedical data are often high-dimensional and noisy. These conven-
tional ML methods are not capable enough to provide suitable techniques to handle such 
natural raw data (i.e., normalized gene expression data).
Different ML-based methods were developed to classify breast cancer patients into one of the 
PAM50 subtypes using gene expression profiles [12]. However, a new class of ML methods 
called deep learning (DL) can handle such high-dimensional, noisy and natural raw data by 
following representation learning or hierarchical data-driven approaches.
2. Deep learning and its application in bioinformatics
DL is a family of artificial neural network (ANN)-based ML methods which have been inspired 
by the working principles of a human brain. In a DL network architecture, a series of hidden 
layers are connected in a cascade fashion between input and output of the network. Each of 
these layers takes input from its previous layer and transforms the data into a more abstract 
form. Nonlinear layers allow DL methods to model complex relations between input and out-
put of the network like shallow ANNs. DL is a representation learning method which means 
it can be fed with raw data and then, it will automatically extract necessary representation for 
predictions. A DL network provides representations at different levels. The output of each of 
hidden layers is considered as the representation at that level. The higher layers the data belong, 
the more abstract representations we get for these data. In different studies, these higher-level 
representations of raw data prove to be very effective for classification or detection problems. 
The most important thing here is that these representations, alternatively called feature vectors, 
are not learned by human engineering rather from the raw input data directly.
Unlike other ML methods, DL methods have been shown to efficiently handle high-dimen-
sional and noise data in many domains such as computer vision, language processing (Table 1). 
These qualities of DL attract biomedical researchers to use DL instead of conventional ML 
methods because biomedical data (e.g., omics data) often suffer from high-dimensionality 
and noisiness.
2.1. How deep learning evolved?
Technological advancement and availability of large data sets allow researchers to rekindle 
their interest in deep neural networks. Recently, DNN-based models have achieved the state-
of-the-art prediction performances at the cost of immense computational power. For example, 
Krizhevsky et al. [13] trained a deep convolutional neural network (DCNN)-based model 
with 1.2 million images to classify 1000 different classes, which took approximately 6 days to 
complete the training. They built this model by optimizing about 60 million learnable param-
eters. They won the ILSVRC-2012 competition with their state-of-the-art prediction perfor-
mances in image classification.
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In computer vision, there has always been a growing need to train visual recognition systems 
more generically so that a system trained on one visual recognition task (e.g., classification) 
could be easily adapted to another task (e.g., detection). To handle such a challenge of adapt-
ing the source domain to different target domains, many domain adaptation methods have 
been proposed [14–16]. For example, Donahue et al. [17] extracted “deep features” from a 
deep neural network trained on one computer vision task and shown the state-of-the-art per-
formance on a variety of other tasks. The DCNN-based features are very powerful, generic 
and, thus, can be well adapted to different visual domains, which was also evidenced by 
Sharif Razavian et al. [18]. They proposed a DCNN-based pretrained model called OverFeat, 
which was applied to different tasks for which OverFeat was not trained. They achieved state-
of-the-art prediction performances for object detection [19]. After having feature descriptors 
extracted from the first fully connected layer of OverFeat, they applied a linear SVM classi-
fier to these features for image classification, scene recognition, fine-grained recognition and 
attribute detection on different data sets. A pretrained CNN is usually followed by domain-
specific fine-tuning on data from the target domains, especially when training data are scarce. 
Following this approach, Girshick et al. [20] fine-tuned a CNN pretrained on ILSVRC2012 clas-
sification data set and achieved substantially better object detection performance on PASCAL 
VOC as compared to the standard models based on simple hand-engineered features.
DL-based models trained using a small data set usually show poor prediction performances 
over the test data. To tackle such kind of overfitting problem, a technique called dropout was 
proposed by Hinton et al. [21]. Dropout is a regularization technique, which randomly drops 
out a predefined ratio of neuron connections within a DL-based network’s layer. This helps 
the model to learn a general weight for each of the neuron connections of that layer. This pro-
cedure allows the network to perform well over the test data. In addition, another technique 
called DropConnect was proposed as a generalization of dropout [22]. It randomly drops out 
of neuron connections from the network instead of randomly dropping neural connection 
from a layer. DropConnect provided improved prediction performances for different image 
recognition benchmark data sets over the dropout [22].
Characteristics Conventional machine learning (including 
shallow neural network)
Deep learning
Feature engineering Handcrafted features created by experts are 
required
Perform automatic feature extraction
Problem-solving 
approach
Break the problems into small parts and solve 
them separately. Combine the results for the 
final output.
Can solve the problems in an end-to-end 
fashion
Execution time Relatively much less time is required (ranging 
from a few seconds to a few hours)
Training requires long time for 
optimizing its thousands of parameters.
Interpretability Relatively easy to interpret the reasoning Hard to interpret the reasoning
High-throughput data It is challenging to handle high-throughput 
data directly
Techniques like dropout enable high-
throughput data processing relatively 
possible
Table 1. Comparison of conventional machine learning and deep learning.
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There is another class of DNN known as deep belief network (DBN). A DBN is composed 
of multiple layers where different layers have neural connections between them but not 
within the hidden units of a layer. Each of these layers is a restricted Boltzmann machines 
(RBMs). DBN follows an unsupervised layer-wise pretraining approach for these RBMs using 
a method called contrastive divergence [23]. DBN is useful to fine-tune a DNN when the num-
ber of training samples is small. In this case, a DBN is first trained and the optimized weights 
from this DBN are then used to fine-tune a DNN. Therefore, this DNN will start the training 
with these learned weights instead of training from the scratch. This leads the network to be 
convergent at early stage and improve prediction performances because these weights are 
neighboring to the best value of a converged model [24].
Stacked autoencoder is another type of DL-based method, which is used to create a vigor-
ous high-level representation of its input using unsupervised ML approaches [24]. A stacked 
autoencoder can be built using a DNN by stacking layers on top of others. With this approach, 
we can increase or decrease the dimension of the input data. Vincent et al. showed that we can 
feed a high-level representation of input data learned from a stacked autoencoder into a SVM 
with improved prediction performance [25].
DL-based methods have already achieved state-of-the-art prediction performances in diverse 
fields such as image classification [26], object detection [13], speech recognition [27], and so on. 
However, DL methods also allow us to build state-of-the-art prediction models for sequential 
data [28, 29]. A series of functionally powerful deep learning tools have been implemented 
(Table 2), which can be publicly downloaded to perform these applications.
Software Website Open 
Source
Interface Deep learning 
algorithms
Caffe http://caffe.berkeleyvision.org/ Yes Python, 
MATLAB
CNN, RNN
Deeplearning4j https://deeplearning4j.org/ Yes Java, Python CNN, RNN, 
RBN, DBN
Keras https://keras.io/ Yes Python, R CNN, RBN, DBN
Theano http://deeplearning.net/software/theano Yes Python CNN, RNN, 
RBN, DBN




Tensorflow https://www.tensorflow.org/ Yes Python, Java CNN, RNN, 
RBN, DBN










Table 2. A list of commonly used deep learning tools.
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CNN, convolutional neural network; RNN, recurrent neural network; RBN, radial basis net-
work; and DBN, deep brief network.
2.2. Application of deep learning to solve different bioinformatics applications
In recent years, deep learning has been successfully applied to answer many biological ques-
tions using diverse biological data sources (Figure 1). We briefly review these advancements 
in different bioinformatics applications in the following paragraphs.
Maienschein-Cline et al. used a conventional unsupervised machine learning approach to 
identify targeted genes which were regulated by transcription factors (TFs) by integrating 
high-throughput binding data and gene expression data [30]. Their experimental results 
showed that the conventional method faced challenges to handle such high-throughput data 
even though they may be very helpful for clinical diagnosis. Therefore, Dananee et al. used 
a DL-based method called stacked denoising autoencoder (SADE) [25] for such kind of anal-
ysis [31]. They first took a high-level representation of the input gene expression profiles. 
They then fed this higher-level representation of the data to a shallow neural network and a 
SVM. They demonstrated the improved prediction performances than the baseline principal 
component analysis (PCA) or kernel principal component analysis (KPCA) approaches. They 
also identified a set of genes from the connectivity matrices of their DL-based model. These 
genes can be investigated further to improve clinical diagnosis.
Somatic point mutation-based cancer classification (SMCC) becomes an attractive research prob-
lem as DNA sequencing technology allows us to generate a huge volume of sequencing data. 
Efficient analysis of the somatic point mutation data can lead to a better patient-specific personal 
therapy to cancer patients. This kind of somatic point mutation data usually suffer from large 
sparsity. Therefore, previous SMCC approaches were not able to provide clinically acceptable 
cancer classification results. However, recently a DL-based classifier known as DeepGene tried to 
overcome this limitation [32]. This model first filtered the gene data by mutation rate to remove 
irrelevant genes from them. Then, it indexed the gene data by their nonzero elements which let 
DeepGene overcome the data sparsity problem. Finally, the outputs of these two steps were fed 
into a DNN which performed automatic extraction of features for SMCC. DeepGene achieved 
~67% prediction accuracy which is much better than the prediction performances of most base-
line classifiers (i.e., SVM ~67%, k-nearest neighbors (KNN) ~42% and naïve Bayes (NB) ~9%).
Figure 1. Scopes of deep learning in bioinformatics.
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DBN was used to cluster cancer patients by integrating their gene expression and clinical 
data [33]. This model can capture intra- and cross-modality correlations (i.e., correlation 
among genomic data from different platforms) and learn a unified representation of the input. 
Therefore, this model outperformed existing methods in clustering cancer patients. This 
model can also be used to predict missing values in the data and identify key target genes of 
miRNAs responsible for different cancer subtypes. Moreover, preliminary clinical screening 
of a patient with skin disease usually begins with a visual diagnosis by a dermatologist. Since 
this is a very common malignancy in a human being [34, 35], an automatic system to classify 
skin diseases will be very helpful for the clinical purpose. Kelley et al. introduced a DCNN 
model to learn the functional activity of DNA sequences for 164 cell-specific DNA accessibil-
ity multitask prediction, and this model achieved the best result among earlier methods [36]. 
Recently, Esteva et al. collected 129,450 clinical images of skin diseases and built a DCNN 
model to classify the disease [37]. This model achieved better prediction performance than 
dermatologists. Nonetheless, a large number of nuclei and the variability in their sizes in his-
topathological images of breast cancer pose a great difficulty to build an automated system 
for nucleus detection. Xu et al. overcame this challenge by using a deep learning approach 
called stacked sparse autoencoder (SSAE). This model outperformed nine previous state-of-
the-art nuclear detection methods [38].
Conventional machine learning approaches have been applied to analyze high-content 
microscopy data to protein subcellular localization from yeast cell images [39]. However, 
these approaches were not able to perform such analysis without human expert’s interven-
tion and yet did not provide accurate classification. Kraus et al. [40] came up with a model 
called DeepLoc which is a DCNN-based approach to overcome these limitations. DeepLoc 
outperforms the model ensLOC [39] by 71.4% according to mean average precision using 
fewer number of images. However, ensLOC uses binary SVM ensemble approach to assign 
single cells to subcellular compartment classes. Kraus et al. [40] also investigated the reason 
behind their success over ensLOC by performing 2D visualization of their network’s compo-
nents. They found out that DeepLoc generates a unique signal for different inputs. The struc-
ture of a protein and its functions can be studied further by protein contact map prediction 
from sequences. Wang et al. [41] treated this problem as a pixel-level labeling by considering 
a protein contact as an image. They proposed a novel deep learning-based protein contact 
map prediction model with extremely unbalanced positive and negative labels. Their model 
integrates two evolutionary couplings (EC) and sequence conservation information into their 
network. Their model gives the state-of-the-art performance result in protein contact map pre-
diction. Furthermore, the predicted protein contacts by this model can generate an improved 
3D structure model than the previous best models: CCMpred [42] and MetaPSICOV [43]. 
Besides, many biological processes such as signal transduction and cellular organization can 
be affected by different protein-protein interactions (PPI). Hence, it is very important to build 
a PPI prediction model in order to provide a better design for the therapy of a disease. Sun 
et al. [44] were the first one to build a deep learning-based model that is a stacked autoencoder 
for the sequence-based PPI prediction. They achieved an accuracy of 97.19% with 10-fold 
cross-validation which is better than any existing PPI predictors.
Genomics becomes rich with many different types of functional genomic data because of the lat-
est sequencing technology. Eser et al. introduced flexible integration of data with deep learning 
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(FIDDLE), which is an open source DCNN-based data integration framework [45]. FIDDLE can 
predict yeast transcription start site sequencing (TSS-seq) [46] by the integration of heterogeneous 
genomic data such as RNA-seq and DNA sequence data. The excellent performance of FIDDLE 
demonstrated that a model built on integrating multiple data sets can provide better prediction 
performances than the models which were built using only one data set.
Chen et al. [47] proposed a deep learning system (D-GEX) which takes a gene’s expression 
profile as input and infers the expression profile of a target gene. D-GEX has the ability to show 
cross-platform generalization. This model archives 15.33% improvement in gene expression 
prediction than a linear regression approach. D-GEX proves its cross-platform generalization 
when the learned D-GEX is used in RNA-seq-based database for gene expression prediction 
for each target gene and still outperforms LR by 6.57%.
Existing methods for the classification of cellular phenotypes from cellular images consist of 
multiple steps. Each of these steps is required with manual modifications and the tuning of 
different parameter settings. Godinez et al. [48] introduced a new multiscale CNN (M-CNN) 
network which uses microscopic images to classify them into phenotypes. The prediction 
performances of the M-CNN in terms of accuracy over eight benchmark data sets are signifi-
cantly higher than the previous state-of-the-art methods including CNN-based approaches.
Gene expression can be regulated using transcription factors (TFs). Therefore, the cell-spe-
cific TF binding predictions using gold standard Chip-seq data are very important. Qin and 
Feng [49] introduced a DNN model termed TFImpute to achieve the abovementioned goal. 
TFImpute can determine whether a specific TF would bind to a given DNA sequence in a 
specific cell line. The prediction performance of TFImpute proves its superiority from the 
comparison with another latest DNN-based approach called DeepBind [50]. Therefore, biolo-
gists can use TFImpute to understand how TF binding can be included by a specific cell line.
Zhou et al. [51] were the first one to propose a DCNN-based approach to predict the effects 
of noncoding-variants from large-scale chromatin-profiling data and achieved state-of-the-art 
predictive performance. They call their method as deep learning-based sequence analyzer 
(DeepSea). Experimental results show that DeepSea can also precisely predict the conse-
quence of specific SNPs on TF binding.
Obtaining precise knowledge about a patient’s health condition is crucial to provide early and 
better treatment. Discovery of good imaging biomarkers can lead clinical research into achiev-
ing this goal. Oakden-Rayner et al. [52] provided a proof-of-concept research which proves 
that computer-based cross-sectional chest CT image analysis is able to predict 5 year mortality 
in adult (age > 60 years) person. Their framework includes deep learning model, and the pre-
dictive performances of this model are better than those who use human-generated features. 
Besides, visualization of different components of this deep learning-based model can provide 
an explanation about the better prediction performances [53].
Gene expression can be controlled by enhancer elements and cis-acting DNA regulatory ele-
ments [54]. However, existing enhancer predictors face a challenge, that is, the lack of avail-
ability of huge and experimentally confirmed enhancers for humans or other species. Yang 
et al. [55] developed a DNN-based hybrid architecture termed as BiRen which takes only 
DNA sequence as input to predict enhancers. Experimental results proved that BiRen can 
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predict common enhances more accurately than previous state-of-the-art methods, which are 
based on DNA sequence only.
Analysis of high-dimensional single-cell RNA-seq data is very important to answer several 
biological questions such as the amount of heterogeneity of cells in a population, the dis-
covery of a biomarker for explicit cells and retrieving analogous cell types. Lin et al. [56] 
introduced an NN-based model to address all these queries without integrating any prior 
knowledge into the model. This method can deduce cell type more properly using a database 
of tens of thousands of single cell profiles than any existing methods.
Although the significant advancements have been made in applying DNN models to differ-
ent bioinformatics applications as described earlier, here, we introduce several DNN-based 
classification frameworks which take either CNA profiles or gene expression profiles or 
both of them as input for the prediction of molecular subtypes of breast cancer. In addition, 
we also present a DNN-based regression model which takes high-dimensional DNAm data 
as input to predict triglyceride concentrations (before and after treatment) in the human 
blood.
3. Case studies
We discussed three case studies where deep learning-based approaches were used to 
address two biological problems such as classification of molecular subtypes of breast cancer 
(Figure 2(a) and (b)) and prediction of triglyceride concentration in human blood (Figure 2(c)).
Figure 2. Deep learning architectures of three different case studies: (a) classification of molecular subtypes of breast 
cancer using single data source; (b) classification of molecular subtypes of breast cancer using multiple data sources; and 
(c) prediction of triglyceride concentration in human blood.
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3.1. Prediction of molecular subtypes of breast cancer
Classification of molecular subtypes of breast cancer using high-throughput genomics data, 
such as gene expressions and copy number alterations (CNAs), is a challenging task because 
we have much smaller number of training samples than the number of genomic features. 
Many traditional machine learning methods often get overfitted over training data to handle 
such a problem. Here, we explored to use DNN methods to overcome this problem.
We conducted our experiments with two data sets: gene expression and CNA. Both data sets 
had approximate 2000 patients and larger than 16,000 genes. We collected these data sets from 
a project called Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) 
[57]. We built a patient by gene mutation matrix from the CNA data where we had only 
three different values to represent three different copy number statuses of a gene in a patient: 
1 = copy number gain, −1 = copy number loss and 0 = no change.
Using the CNA profiles of 991 and 984 patients as training and test sets, respectively, which 
was separated in original study [56] based on the patients collected at different periods, 
we classified the status of estrogen-receptor as a supervised binary classification problem. 
Furthermore, using the CNA profiles of 935 and 842 patients as training and test sets, respec-
tively, we classified the status of PAM50 subtypes (luminal A, luminal B, HER-2 enriched and 
basal-like) as a supervised multiclass classification problem (it should be noted that some 
patients have no status of the PAM50 subtypes). Our DCNN-based deep learning architecture 
used for the tasks is shown in Figure 2(a) [58].
Our network took a CNA profile with approximate 16,000 genes of a breast cancer patient 
as the input in the input data layer. The input layer passed this input data to a convolutional 
layer. In the convolutional layer, we passed a kernel with weights over the input data and 
performed an element-wise multiplication with the input data. Then, we took the sum of the 
elements from this operation to represent the input data. This operation helped us capture 
the potential correlations among the neighbor genes. Output from the convolutional layers 
went as an input into max pooling layer. Here, we also passed a kernel without any weights 
over the input of this layer. We then took the maximum value from the input data under the 
kernel to represent the input data. This operation helped the model to achieve three invari-
ant properties such as scaling, translation, and rotation. We introduced nonlinearity into our 
model by passing the output from max pooling layer through a rectified linear unit (ReLu) 
layer. ReLu layer performed a thresholding operation by converting all values less than zero 
to zero. At this point, we passed the output from the ReLu layer to a fully connected layer 
to get the higher level abstraction. We then passed the output from this fully connected to a 
dropout layer where we used another ReLu between them. Dropout layer randomly dropped 
out a number of neurons from the network. Dropout strategy enforced the network to learn a 
general weight for each of the neurons of the network. This helped the model to achieve better 
generalization ability over the test data as well as prevented the model from the overfitting 
problem. Then, we used another fully connected layer to get the prediction score for each of 
the classes. We converted this class score into class probability using softmax function. We 
trained our network in backpropagation style.
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We evaluated the prediction performances of our network by two metrics such as overall 
accuracy and area under the curve (AUC). We achieved 84.1% accuracy and 0.904 AUC for 
binary classification. On the other hand, for multiclass classification, we achieved 58.19% 
accuracy and 0.79 AUC. We compared our experimental outcomes with other two supervised 
machine learning methods such as support vector machine (SVM) and random forest (RF). 
Prediction performances of SVM for the binary classification were 76.5% accuracy and 0.702 
AUC while 45.0% accuracy and 0.78 AUC for multiclass classification. With RF, we had 82.7% 
accuracy and 0.817 AUC for binary classification and 49.5% accuracy and 0.729 AUC for mul-
ticlass classification. Our experimental outcomes showed that deep learning-based models 
have better performance than the traditional machine learning methods such as SVM and RF.
We also explored to build DCNN-based network (Figure 2(b)) to classify the status of PAM50 
subtypes using both gene expression and CNA data. One of these data sets may have biologi-
cal knowledge which is absent in another one. Our network shown in Figure 2(b) had two 
branches: i and j branches which took CNA data and the gene expression data of the same 
patient as inputs, respectively. Each of these branches performed the same series of operations 
over the input data. Outputs of the last fully connected layers from both branches were concat-
enated to be fed into the third part of the network which provided the final predictions. Here, 
we also used overall accuracy and AUC as the performance measurement metric. In terms of 
prediction performances, our model achieved 79.2% accuracy and 0.85 AUC. We compared 
our prediction performances with two baseline models: SVM and RF. Their prediction perfor-
mances in terms of overall accuracy were 69.5 and 70.1%, respectively. Besides, our baseline 
models provided AUC 0.804 and 0.781, respectively. From these comparisons, we can clearly 
see that our deep learning-based data integration model (Figure 2(b)) achieved improved pre-
diction performances than all of our baseline models. Our data integration model also outper-
formed the models (Figure 2(a)) which were built using only one data source as input to the 
architecture.
3.2. Prediction of triglyceride concentration
Triglyceride is a kind of fat which is found in human blood. Excessive triglyceride concentration 
can cause different heart-related diseases such as stroke. In this experiment, we built a DNN-
based regression model [59], which took epigenome-wide DNA methylation profiles as input 
to predict triglyceride concentration at multiple draw of peripheral human blood samples.
For our experiments, we collected the epigenome-wide DNAm profiles and triglyceride 
concentrations (mg/dL) measured at the baseline level (pretreatment) of visit 2 and changes 
in response to treatment with fenofibrate (posttreatment) at visit 4 from Genetic Analysis 
Workshop 20 (GAW20). The DNAm profiles were generated using the Illumina Infinium 
HumanMethylation450 BeadChip array. The beta value measuring the methylation level was 
expressed between 0 and 1 in 993 samples of the Genetics of Lipid Lowering Drugs and Diet 
Network (GOLDN) study. It should be noted that there were only 499 samples with the post-
treatment DNAm data. Here, we built three regression models to solve three tasks: (1) we 
used pretreatment data to predict triglyceride concentration before the medication. We built 
this model using 900 randomly selected training samples, and we had 93 test samples for 
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the purpose of testing the model’s prediction performances; (2) we used posttreatment data 
to predict triglyceride concentration after the medication. In this case, we had 400 randomly 
selected training samples and 99 test samples; (3) we used pretreatment data to predict tri-
glyceride concentration after the medication. Here, we had 620 randomly selected training 
samples and 94 test samples.
Our DNN-based regression model (Figure 2(c)) is a fully connected neural network with four 
hidden layers between input and output layers. This network took a vector of size larger than 
450,000 which represented an epigenome-wide DNA methylation profile of a sample. This 
vector went through two full connected layers, and the output is the higher level abstraction 
of the input. Then, we used a ReLU layer to introduce nonlinearity into the model, and the 
output of ReLU went into a dropout layer to achieve the generalization ability to test the data. 
The output of dropout layer then went into the final output layer and provided the predicted 
triglyceride concentration.
We used root mean square error (RMSE) and Pearson correlation coefficient (PCC) to measure 
our prediction performances. Prediction performances of our DNN-based regression models 
are as follows: for Task 1, we had RMSE 88.5 and PCC 0.27; for Task 2, we had RMSE 48.1 
and PCC 0.22 and for Task 3, we had RMSE 47.4 and PCC 0.29. We used SVM as our baseline 
model. SVM provided prediction performances are as follows: for Task 1, the RMSE was 90.3 
and PCC was 0.13; for Task 2, the RMSE was 48.7 and PCC was 0.19 and for Task 3, the RMSE 
was 46.9 and PCC was 0.13.
Experimental results showed that our DNN-based triglyceride concentration regression mod-
els provided improved prediction performances for all three tasks than the baseline SVM-
based regression method. Both our DNN-based and SVM-based regression models achieve 
best prediction performances when we used the pretreatment data to predict triglyceride con-
centration after the medication. This outcome shows that there is a long-term epigenetic effect 
on the phenotypic traits.
4. Conclusion
Classification of molecular subtypes of a disease using omics profiles is a challenging prob-
lem since the data sets are quite high-dimensional and highly correlated. The curse of high-
dimensionality also affects the performance of predicting a phenotype using DNAm data. 
Traditional machine learning algorithms, such as SVM and RF, have potential challenges to 
handle high-dimensional and highly correlated data sets. Recently, DNN learning has been 
demonstrated advantages over these methods since it does not require any hand-crafted fea-
tures. DNN learning automatically extracts features from the raw data and efficiently analyzes 
high-dimensional and correlated data. In this chapter, we reviewed the status of applying 
DNN in bioinformatics and showed some case studies which introduced several DNN frame-
works for classifying molecular subtypes of breast cancer using only one data source or two 
heterogeneous data sources. In addition, we also presented a DNN-based regression frame-
work which took epigenome-wide DNAm data as input to predict triglyceride concentrations 
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in human blood. In summary, our and others’ works have demonstrated that DNN is a prom-
ising tool to predict phenotypic traits and diseases from genome-wide omics data.
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